NPPNY
Price
$5.31
Change
-$0.05 (-0.93%)
Updated
Jun 25 closing price
Capitalization
2.75B
OMID
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
Jun 25 closing price
Capitalization
N/A
69 days until earnings call
Interact to see
Advertisement

NPPNY vs OMID

Header iconNPPNY vs OMID Comparison
Open Charts NPPNY vs OMIDBanner chart's image
Nippon Shinyaku
Price$5.31
Change-$0.05 (-0.93%)
Volume$554
Capitalization2.75B
Omid
Price$0.02
Change-$0.00 (-0.00%)
Volume$650
CapitalizationN/A
NPPNY vs OMID Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NPPNY vs. OMID commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NPPNY is a Hold and OMID is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (NPPNY: $5.31 vs. OMID: $0.02)
Brand notoriety: NPPNY and OMID are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NPPNY: 8% vs. OMID: 2%
Market capitalization -- NPPNY: $2.75B vs. OMID: $0
NPPNY [@Pharmaceuticals: Other] is valued at $2.75B. OMID’s [@Pharmaceuticals: Other] market capitalization is $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NPPNY’s FA Score shows that 2 FA rating(s) are green whileOMID’s FA Score has 1 green FA rating(s).

  • NPPNY’s FA Score: 2 green, 3 red.
  • OMID’s FA Score: 1 green, 4 red.
According to our system of comparison, NPPNY is a better buy in the long-term than OMID.

Price Growth

NPPNY (@Pharmaceuticals: Other) experienced а -14.08% price change this week, while OMID (@Pharmaceuticals: Other) price change was -18.09% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.94%. For the same industry, the average monthly price growth was +13.35%, and the average quarterly price growth was +95.35%.

Reported Earning Dates

NPPNY is expected to report earnings on May 08, 2025.

OMID is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.94% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
NPPNY YTD gains are higher at: -20.030 vs. OMID (-22.025).
NPPNYOMIDNPPNY / OMID
Capitalization2.75BN/A-
EBITDA36BN/A-
Gain YTD-20.030-22.02591%
P/E Ratio16.53N/A-
Revenue141BN/A-
Total Cash64.4BN/A-
Total Debt2.11BN/A-
FUNDAMENTALS RATINGS
NPPNY vs OMID: Fundamental Ratings
NPPNY
OMID
OUTLOOK RATING
1..100
9079
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
77
Overvalued
PROFIT vs RISK RATING
1..100
10092
SMR RATING
1..100
141
PRICE GROWTH RATING
1..100
6491
P/E GROWTH RATING
1..100
7968
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NPPNY's Valuation (23) in the null industry is somewhat better than the same rating for OMID (77). This means that NPPNY’s stock grew somewhat faster than OMID’s over the last 12 months.

OMID's Profit vs Risk Rating (92) in the null industry is in the same range as NPPNY (100). This means that OMID’s stock grew similarly to NPPNY’s over the last 12 months.

OMID's SMR Rating (1) in the null industry is in the same range as NPPNY (14). This means that OMID’s stock grew similarly to NPPNY’s over the last 12 months.

NPPNY's Price Growth Rating (64) in the null industry is in the same range as OMID (91). This means that NPPNY’s stock grew similarly to OMID’s over the last 12 months.

OMID's P/E Growth Rating (68) in the null industry is in the same range as NPPNY (79). This means that OMID’s stock grew similarly to NPPNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACECX10.78N/A
N/A
American Century Emerging Markets C
MSFJX19.51N/A
N/A
MFS Total Return R4
MPDIX11.43N/A
N/A
MassMutual Disciplined Gr I
USRAX32.14N/A
N/A
Horizon Multi-Factor U.S. Equity Inv
RIERX12.85N/A
N/A
RBC International Equity R6

NPPNY and

Correlation & Price change

A.I.dvisor tells us that NPPNY and MEDIF have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NPPNY and MEDIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NPPNY
1D Price
Change %
NPPNY100%
-0.93%
MEDIF - NPPNY
11%
Poorly correlated
-9.45%
OVATF - NPPNY
10%
Poorly correlated
N/A
OMID - NPPNY
3%
Poorly correlated
N/A
MGWFF - NPPNY
0%
Poorly correlated
N/A
OILFF - NPPNY
-1%
Poorly correlated
+3.49%
More

OMID and

Correlation & Price change

A.I.dvisor tells us that OMID and OWPC have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OMID and OWPC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OMID
1D Price
Change %
OMID100%
N/A
OWPC - OMID
10%
Poorly correlated
+6.53%
OILFF - OMID
9%
Poorly correlated
+3.49%
RGEDF - OMID
6%
Poorly correlated
N/A
RAFA - OMID
3%
Poorly correlated
N/A
PHCUF - OMID
3%
Poorly correlated
N/A
More